Skip to main content
Clinical Trials/ACTRN12614000980639
ACTRN12614000980639
Completed
Phase 4

A randomised clinical trial to compare the efficacy of the intravenous midazolam-droperidol combination, droperidol only and olanzepine only for sedation of the severely agitated patient

Austin Hospital0 sites342 target enrollmentSeptember 12, 2014

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Austin Hospital
Enrollment
342
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Austin Hospital

Eligibility Criteria

Inclusion Criteria

  • Emergency Department patients aged 18\-65 years who require IV drug sedation for acute agitation

Exclusion Criteria

  • 1\. known hypersensitivity or contraindication to the study drugs
  • 2\. reversible aetiology for agitation (hypotension, hypoxia, hypoglycaemia)
  • 3\. known pregnancy
  • 4\. acute alcohol withdrawal (particularly amenable to benzodiazepines alone)

Outcomes

Primary Outcomes

Not specified

Similar Trials